mPhase Technologies, Inc. (XDSL) (http://mphasetech.com/),
today provided an update on it’s patent application for a Drug Delivery
System that is based on mPhase Technologies’ award winning advanced
battery technology, recognized by Frost and Sullivan with its’ 2013
North American Advanced Battery Technology Innovation Award for Best
Practices.
This research lead to the expansion of mPhase’s Intellectual Property
which utilizes mPhase’s smart surface technology.
In February of 2013 mPhase filed a United States Letter Patent
Application for a novel drug delivery system based on its Smart Surface
technology. In December of 2013 the patent application for the Smart
Drug Delivery System received a first review (Office Action) by the
United States Patent and Trademark Office. The patent office examiner
indicated that a significant portion of the claims were patentable. A
response to the office was filed, without amending the claims, but with
strong arguments as to why all of the claims are patentable. mPhase is
now waiting for a response from the patent office which is expected no
later than in the first quarter of 2015.
The drug delivery patent is based on mPhase's Smart Surface technology
enabling the automatic dispensing of a pre-set dosage of a drug agent or
medication. mPhase believes the issuance of a patent could lead to
licensing opportunities for the technology, including licensing for a
novel drug delivery system, possibly creating greater shareholder value.
The field of invention relates to a drug delivery system that generally
includes a housing having one or more reservoirs; each having a medical
agent hermetically sealed therein. A membrane extends across each of the
one or more reservoirs which is adapted to allow the medical agents to
pass there through in response to external stimuli, such as physical
puncturing, melting the membranes through use of heating elements or
electrowetting in response to a voltage pulse. A wicking material
extends across the membranes through which the medical agents are
dispensed to a patient. Because the housing can be made flat, the
overall dispensing device can be reduced in size, allowing the drug
delivery device to be located and attached to broader areas of the
patient’s body for expanded medical applications and treatment.
Under past Cooperative Research and Development Agreements with the
United States Army, mPhase developed a smart surface that made it
possible to keep the essential components of a battery, the solid
electrode and liquid electrolyte, separated until power is needed. This
battery system, the Smart Nanobattery, can be activated electronically,
mechanically or via gravitational pull.
About mPhase Technologies, Inc. mPhase Technologies Inc. (XDSL),
a 2013 Frost and Sullivan recipient for the North American Advanced
Battery Technology Innovation Award. mPhase Technologies is a publicly
traded company (XDSL) that is pioneering a revolutionary Smart Surface
technology enabled by breakthroughs in nanotechnology, MEMS processing
and microfluidics. Our Smart Surface technology has potential
applications within drug delivery systems, lab-on-a-chip analytic
systems, self-cleaning systems, liquid and chemical sensor systems, and
filtration systems. mPhase has pioneered its first Smart Surface enabled
product, the mPhase Smart NanoBattery, still in development. More
information about the company can be found at http://www.mPhaseTech.com.
About mPower Technologies
mPower Technologies Inc. is the wholly owned consumer products
subsidiary of mPhase Technologies, Inc. More information about the
company can be found at http://www.mpowertech.com.
Forward-Looking Statements. As a cautionary note to investors,
certain matters discussed in this press release may be forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Such matters involve risks and uncertainties that
may cause actual results to differ materially, including the following:
changes in economic conditions; general competitive factors; acceptance
of the Company's products in the market; the Company's success in
technology and product development; the Company's ability to execute its
business model and strategic plans; and all the risks and related
information described from time to time in the Company's SEC filings,
including the financial statements and related information contained in
the Company's SEC Filing. mPhase assumes no obligation to update the
information in this release.
Copyright Business Wire 2014